AMA Policies and Code of Medical Ethics' Opinions Related to Cancer Prevention in Low- and Middle-Income Countries
Bibliographic Data
| ID | 15745470 |
|---|---|
| Authors | Andi Sirokman (corresponding author) |
| Year | 2020 |
| Volume | 22 |
| Issue | 2 |
| Pages | E112-115 |
| Publication date | 2020-02-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/amajethics.2020.112 |
| PMID | 32048581 |
| OpenAlex | W3003172732 |
| Language | EN |
| Citations received | 2 |
| References cited | 1 |
Cancer is the second leading cause of death globally. Death rates from cancer reflect global inequality; approximately 70% of deaths from cancers occur in low- and middle-income countries (LMICs). Due to high costs of cancer treatment and limited access to resources, these countries are unable to use treatment as a primary means for reducing cancer burden. Thus, redirecting focus from treatment to prevention in LMICs and considering prevention as a global public health imperative are critical. The AMA Code of Medical Ethics and policies can guide efforts to promote and support cancer prevention in LMICs
Cancer · Cancer survival · Developing country · Development economics · Economic growth · Economics · Environmental health · Inequality · Low and middle income countries · Economic and Financial Impacts of Cancer · Ethics in Clinical Research · Health Systems, Economic Evaluations, Quality of Life · Medicine · Internal Medicine
| Citations per year | 0.33 |
|---|---|
| Citation span | 2020 - 2022 (3) |
| Highly cited | No |